Oppenheimer Reiterates Outperform on UnitedHealth Group, Maintains $610 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on UnitedHealth Group (NYSE:UNH) and maintained a price target of $610.
January 17, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst reaffirms Outperform rating on UnitedHealth Group with a $610 price target, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a prominent analyst like Michael Wiederhorn suggests a strong vote of confidence in UnitedHealth Group's future performance. The maintained price target of $610 indicates a positive expectation for the stock's growth potential, which could influence investor sentiment and potentially drive the stock price upward in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100